<qa>  What is the target of the retrospective study?This retrospective study aims to assess treatment patterns within 1 year of initiating BPH treatment, including 5-alpha-reductase inhibitor 5ARI monotherapy, alpha-blocker AB monotherapy, early combination therapy, and delayed combination therapy. The MarketScan database will be utilized for this study 2000-2008 